Categories: Market

Lupin shares up nearly 4% on FII cap hike

Mumbai, February , 2015

Shares of Lupin gained nearly 4 per cent today after the Reserve Bank said foreign institutional investors and registered foreign portfolios investors can now invest up to 49 per cent of the paid-up capital in the company under Portfolio Investment Scheme (PIS).

The stock settled 3.66 per cent higher at Rs. 1,679.05 on the BSE. During the day, it gained 4.29 per cent to Rs. 1,692.50 – its 52-week high. At the NSE, it rose by 3.67 per cent to close at Rs. 1,677.

In terms of volume, 1.07 lakh shares of the company changed hands at the BSE and over 17 lakh shares were traded at the NSE during the day.

“The company has passed resolutions at its Board of Directors’ level and a special resolution by the shareholders, agreeing for enhancing the limit for the purchase of its equity shares and convertible debentures by FIIs/RFPIs,” RBI had said.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago